An industry survey of implementation strategies for clinical supply chain management of cell and gene therapies-Reference-Cited by-同舟云学术

An industry survey of implementation strategies for clinical supply chain management of cell and gene therapies

Published:2021-11 Issue: Volume: Page:
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Myles Lequina^ORCID,Church Terry David

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference90 articles.

1. Advanced therapy medicinal products: current and future perspectives;Hanna;J Mark Access Health Policy,2016

2. Gene therapies development: slow progress and promising prospect;Hanna;J Mark Access Health Policy,2017

3. Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders;Shahryari;Front Genet,2019

4. Cell & gene therapies calling for innovation in drug development;Gerlovin;Drug Development and Delivery,2018

5. Alliance for Regenerative Medicine. 2020: Growth & Resilience in Regenerative Medicine. 2020 [cited 2021 Aug 22]. Available from: https://alliancerm.org/sector-report/2020-annual-report/

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A quest for stakeholder synchronization in the CAR T-cell therapy supply chain;Frontiers in Bioengineering and Biotechnology;2024-08-08

2. Optimizing long-term stability of siRNA using thermoassemble ionizable reverse pluronic-Bcl2 micelleplexes;International Journal of Biological Macromolecules;2024-04

3. Expanding access to CAR T cell therapies through local manufacturing;Nature Biotechnology;2023-10-26

4. Critical path activities in clinical trial setup and conduct: How to avoid bottlenecks and accelerate clinical trials;Drug Discovery Today;2023-10

5. Why mRNA-ionizable LNPs formulations are so short-lived: causes and way-out;Expert Opinion on Drug Delivery;2023-01-01